Thursday, January 19, 2017

FDA issues final 503A compounding guidance prohibiting office use

Pharmacy Today, American Pharmacists Association, pharmacist.com-Jan 17, 2017
APhA already has submitted joint comments with other pharmacy organizations and stakeholders to the incoming Trump administration opposing the final ...

Roaches, Mold and Dust, Oh My..The FDA issued a new report detailing the results of 350 compounding pharmacy inspections that found numerous “insanitary” conditions

Roaches, Mold and Dust, Oh My

Pharmacy Practice News-Jan 18, 2017
The FDA issued a new report detailing the results of 350 compounding pharmacy inspections that found numerous “insanitary” conditions, including mold, ...